Welcome to the

Primovist® (gadoxetic acid)

Knowledge Base

This online resource provides an illustrated overview of clinical
applications for Primovist®-enhanced MRI in liver diseases.

Particular emphasis is given to the following types of focal liver lesions:

Module 1: Hepatocellular carcinoma (HCC)
Module 2: Hepatic metastases including their surveillance, diagnosis, decision making, and posttreatment monitoring for response assessment and follow-up.

Each section within the modules is divided as follows: Primovist^® study data, and supporting endorsements from international guidelines. Multiple-choice questions with answers are provided at the end of each section for readers to self-assess their knowledge.

This resource is developed for hepatologists, gastroenterologists, liver surgeons, oncologists, and other healthcare professionals who care for patients with liver disease in collaboration with radiological services. All parts of the resource are intended to be of interest to these specialties.

The Modules

Module 1:

Hepatocellular carcinoma (HCC)

Module 2:

Hepatic metastases

Resources

To assist users of this resource, the following supporting materials are included:

Lexicon

A lexicon explaining commonly used terms.

Clear direction. > From diagnosis to care.

Every day it’s your expertise that provides clear direction on a patient’s clinical journey.
Putting an end to uncertainty.